Pharmaceutical
Status Yellow High Temperature Warning Issued for Ireland - Your Complete Health & Safety Guide
Met Éireann has issued a Status Yellow High Temperature Warning for Ireland. Here is everything you need to know: how to protect yourself and your family, what to eat and drink, what to keep at home, and the key precautions recommended by HSE and public health experts.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Pharmaceutical
Eisai Allocates £48M to UK Cold-Chain Pharma Packaging Hub
Japanese pharmaceutical company Eisai announces a £48 million investment at its Hatfield, UK site to establish advanced cold-chain supply and packaging capabilities, supported by the Life Sciences Innovative Manufacturing Fund.
Pharmaceutical
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.
Pharmaceutical
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Enterprise Ireland has announced record total exports of €38.86 billion. With the Advanced Manufacturing and Life Sciences sector surging by 14% to €13.16 billion, we analyse what this means for Ireland's homegrown pharma ecosystem.
Pharmaceutical
Ireland in the Crosshairs: How New U.S. Tax Rules and Trade Policies Threaten the Irish Pharma Boom
New U.S. disclosure regulations and aggressive "America First" trade policies from the Trump administration have exposed the massive tax payments of U.S. pharmaceutical giants in Ireland, placing the country's fiscal stability under intense scrutiny.
Pharmaceutical
The EU Pharma Package and Critical Medicines Act: What Global Companies Need to Know in 2026
The European Union's new General Pharmaceutical Legislation and the Critical Medicines Act have been finalized, representing the most significant overhaul of European medicines law in over two decades. Here is what global companies must know to adapt.
Pharmaceutical
Avectas: Engineering the Future of Cell Therapy Manufacturing
Recognizing the critical industry bottleneck in scalable cell therapy production, Avectas has announced a landmark collaboration with CCRM and OmniaBio to evaluate its innovative manufacturing platform.
Pharmaceutical
The Weight-Loss Drug Boom: Novo Nordisk's €432 Million Athlone Expansion
Novo Nordisk commits €432 million to upgrade its Athlone facility, expanding manufacturing capacity for oral GLP-1 weight-loss and diabetes treatments.
Pharmaceutical
From Powerhouse to Pioneer: How Ireland's Life Science Sector Is Pivoting from Manufacturing to an R&D-Led Innovation Hub in 2026
An in-depth analysis of Ireland's National Life Science Innovation Strategy in 2026. We examine the structural challenges of this transition-including specialised R&D infrastructure, the acute talent shortage in cell and gene therapies (CGT), and how digital compliance tools like Priya LifePDF streamline the transition.
Pharmaceutical
Why Ireland Remains the Global Pharma Hub: Analyzing the Historic $6.6 Billion Eli Lilly Tax Disclosure
The June 2026 country-by-country disclosures revealed that Eli Lilly paid $6.6 billion in Irish corporation tax-double its US federal liability. We analyze why Ireland remains the ultimate hub for global pharma despite the OECD 15% minimum tax.
Pharmaceutical
How the Iran Conflict Is Disrupting Ireland’s Pharmaceutical Industry and Why It Matters Globally.
Middle East air route disruptions are raising costs and delaying Ireland’s pharma exports, impacting global medicine supply chains.